Press Coverage, page-3

Hi Metrader,
Quoting from Whimn article today,  :

"The first human trial of the treatment began in 2016 and Professor Coward says they are testing whether the drug is safe and efficacious and will work out the optimum dose.
Women taking part in the trial so far have reported no major side effects and the treatment is being used in conjunction with standard chemotherapy. If the treatment proves successful, it may be trialled in other cancers such as colorectal, stomach and pancreatic."
I think that is the best news so far in the trial.
Regards.